Here are the top five gainers by percentage on the Nasdaq before the market opened.
Incannex Healthcare Ltd (NASDAQ:IXHL)
Incannex Healthcare Ltd is developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions.
Price: 0.2841
Percentage Change: 222.27%
Volume: 154,718,428
Septerna Inc (NASDAQ:SEPN)
Septerna is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by its proprietary Native Complex Platform.
Price: 10.98
Percentage Change: 63.45%
Volume: 12,068,586
Innovative Eyewear Inc (NASDAQ:LUCY)
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow the customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection.
Price: 3.17
Percentage Change: 1.19%
Volume: 16,864,958
B Riley Financial Inc (NASDAQ:RILYG)
B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional and high net worth clients and also asset disposition, valuation and appraisal and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe.
Price: 10.49
Percentage Change: 54.04%
Volume: 1
Bluebird bio Inc (NASDAQ:BLUE)
bluebird bio Inc is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company’s gene therapy procedures aim to genetically modify a patient’s cells to fundamentally correct or address the genetic basis underlying a disease.
Price: 4.92
Percentage Change: 48.91%
Volume: 2,126,044
Premarket Sentiment
Gainers – 1521 (50%)
Losers – 1203 (40%)
Unchanged – 274 (9%)
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.